International Stem Cell Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISCO research report →
Companywww.internationalstemcell.com
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products.
- CEO
- Andrey Semechkin
- IPO
- 2007
- Employees
- 32
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $1.44M
- P/E
- -3.77
- P/S
- 0.16
- P/B
- 17.15
- EV/EBITDA
- -3.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 56.98%
- Op Margin
- -2.61%
- Net Margin
- -4.11%
- ROE
- 50.13%
- ROIC
- -63.52%
Growth & Income
- Revenue
- $9.10M · 0.17%
- Net Income
- $-418,000 · -100.00%
- EPS
- $-0.05 · -91.57%
- Op Income
- $-267,000
- FCF YoY
- 77.12%
Performance & Tape
- 52W High
- $0.27
- 52W Low
- $0.11
- 50D MA
- $0.16
- 200D MA
- $0.15
- Beta
- 0.14
- Avg Volume
- 2.84K
Get TickerSpark's AI analysis on ISCO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 17, 25 | Don Wright | other | 532,786 |
| Jun 17, 25 | Don Wright | other | 30,000 |
| Nov 6, 23 | Semechkin Andrey | other | 500,000 |
| Nov 6, 23 | Kern Russell | other | 2,000,000 |
| Jun 14, 23 | Don Wright | other | 445,205 |
| Jun 14, 23 | Don Wright | other | 30,000 |
| Jun 14, 23 | MAIER PAUL V | other | 445,205 |
| Jun 14, 23 | MAIER PAUL V | other | 30,000 |
| Jun 14, 23 | Kern Russell | other | 500,000 |
| Jun 9, 21 | Garnette Sophia | other | 250,000 |
Our ISCO Coverage
We haven't published any research on ISCO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ISCO Report →